10mg/20mg/30mg options
 
Retatrutide is a novel medication currently under investigation for the treatment of obesity and type 2 diabetes. It is a triple receptor agonist that targets glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. 
Benefits of Retatrutide: 
Reduced liver fat:
Studies have demonstrated that retatrutide can significantly reduce liver fat in individuals with obesity and non-alcoholic fatty liver disease (NASH). 
Enhanced satiety:
Retatrutide regulates appetite by activating GLP-1 and GIP receptors, leading to a feeling of fullness after eating. 
Potential for cardiovascular benefits:
Preliminary research suggests that retatrutide may improve cardiovascular risk factors, such as blood pressure and cholesterol. 
Possible benefits for type 2 diabetes:
Retatrutide may be effective in managing blood sugar levels and reducing the need for diabetes medications in individuals with type 2 diabetes. 
Significant weight loss:
In clinical trials, retatrutide has shown substantial weight loss compared to placebo. Participants experienced an average weight loss of 12-24% over 48 weeks. 
Improved metabolic health:
Retatrutide has been found to improve insulin sensitivity, reduce blood sugar levels, and lower cholesterol.